Contract Supplement Manufacturing · Połchowo, Poland
One partner, one platform — from concept to shelf.
Supply Chain as a Service for the supplement industry.
18.4M PLN
Revenue 2024
60
Days to market
61+
Active SKUs
2022
Founded
Infoshare 2026 · Pomeranian Startup Contest
The European supplements market is estimated at ~€45B and growing — yet the supply chain remains fragmented, expensive and opaque for emerging brand owners.
Launching a single SKU via traditional CMO relationships typically takes up to a year.
High minimum order quantities and upfront costs lock out small and mid-size brand owners.
Manufacturer, packaging, labels, QC, logistics — each requires a separate contract.
Batch tracking, delivery timelines and quality documentation are often inconsistent.
Poland ranks among the top 5 supplement markets in Europe. Direct-to-consumer health brands are growing rapidly — yet access to pharma-grade manufacturing remains limited for new entrants.
BGW Pharma is a vertically integrated contract manufacturer with a proprietary digital platform. We handle R&D, sourcing, production, packaging, QC and delivery — all in-house.
B2B contract manufacturing for brand owners — internal estimate.
D2C brands, fitness creators, pharmacies — based on current pipeline.
Growth in D2C health products and micro-brand launches is driving demand for faster, more flexible contract manufacturing.
Formula development tailored to your brand. 61+ active SKUs in production.
Qualified raw materials from audited, certified suppliers.
Manufacturing & packaging in GMP-certified facility with full batch documentation.
Quality control, traceability and timely delivery.
BGW Flow (planned Q2 2026): Self-service portal with AI-assisted pricing and mobile tracking. Clients configure products, receive quotes and monitor production in real time.
Financial data sourced from KRS / BizRaport.pl. 379K PLN public support received in 2025.
| Type of player | Integrated CMO | Digital platform | Fast launch | AI pricing | Private label |
|---|---|---|---|---|---|
| BGW Pharma | ✔ | ✔ | ✔ | ✔ | ✔ |
| Traditional CMO | ✔ | ✗ | ✗ | ✗ | ~ |
| Ingredient brokers | ✗ | ✗ | ✗ | ✗ | ✗ |
| Digital ordering platforms | ✗ | ✔ | ~ | ~ | ✗ |
| Private label packagers | ~ | ✗ | ~ | ✗ | ✔ |
✔ full · ~ partial · ✗ absent · Based on internal market assessment.



Production + Commercial + Operations. Every link in the chain covered.
2027 outlook: International expansion & SaaS model · Supply Chain as a Service for Europe
Roadmap reflects current plans and targets. Subject to change based on business conditions.
BGW Pharma — contract supplement manufacturing,
from concept to shelf in 60 days.
18.4M PLN
Revenue 2024
60
Days to market
19×
Growth 2022–24
Profitable
Every year
bgwpharma.com · Połchowo, Poland
Financial figures sourced from KRS / BizRaport.pl. This material is for informational purposes only.